A Pragmatic Trial of the TabCAT Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the effectiveness of the paradigm on detection rates and other brain health outcomes via a pragmatic cluster randomized trial in 26 Kaiser Southern California primary care clinics.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient with at least one encounter at an intervention clinic during the intervention period
• Age 18+ (limited to 65+ for primary analyses)
Locations
United States
California
Kaiser Permanente Southern California Department of Research & Evaluation
RECRUITING
Pasadena
Contact Information
Primary
Collette Goode, BS
collette.goode@ucsf.edu
415-514-0881
Backup
Katherine Possin, PhD
katherine.possin@ucsf.edu
415-476-1889
Time Frame
Start Date: 2023-07-27
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 180000
Treatments
Experimental: TabCAT-Brain Health Assessment Clinical Pathway
Primary care providers concerned that their patients are exhibiting signs of cognitive decline based on patient, informant (family), or provider concerns will refer them for a TabCAT-BHA assessment and follow-up care.
No_intervention: Usual Care Clinical Pathway
Patients in the control practices will continue with usual care workflows.
Related Therapeutic Areas
Sponsors
Leads: University of California, San Francisco
Collaborators: Kaiser Permanente, National Institute of Neurological Disorders and Stroke (NINDS)